A New Approach To Predicting Prognosis In Sars-Cov-2 Infection: "MELD Scoring"
Öz
Background/Aims: The MELD score is a scoring system used to assess the severity of end-stage liver disease. In our study, we aimed to investigate the role of MELD score in predicting the course of the disease and mortality in COVID-19 disease with multi-systemic involvement.
Methods: Our study was conducted with 96 patients over the age of 18 who were diagnosed with COVID-19 by real time PCR method by taking nasopharyngeal swabs between March 2021 and March 2022. MELD score was calculated according to the blood results of the patients at the time of hospital admission. To calculate the MELD score, the equation MELD = 11.2 x ln(international normalized ratio [INR]) + 3.78 x ln(bilirubin, mg/dL) + 9.57 x ln(creatinine, mg/dL) + 6.43 was used.
Results: We found that the MELD score was significantly higher in the moderate and severe patient group compared to the mild patient group (p<0.01). When we compared the moderate and severe patient groups between themselves, the MELD score was significantly higher in the severe patient group (p<0.01). In the evaluation of the association of MELD score with mortality, a one-unit increase in MELD score was associated with a 1.26-fold (95% confidence interval: 1.10-1.44) increased mortality risk.
Conclusions: In our study evaluating the MELD score in COVID-19 patients, it was observed that the MELD score during hospitalization was closely associated with disease severity and mortality. Therefore, the MELD score may be a guiding scoring system in the early follow-up of COVID-19 patients.
Anahtar Kelimeler
Kaynakça
- Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327-31.
- King JT, Jr., Yoon JS, Bredl ZM, Habboushe JP, Walker GA, Rentsch CT, et al. Accuracy of the Veterans Health Administration COVID-19 (VACO) Index for predicting short-term mortality among 1307 US academic medical centre inpatients and 427 224 US Medicare patients. J Epidemiol Community Health. 2022;76(3):254-60.
- Rahman T, Al-Ishaq FA, Al-Mohannadi FS, Mubarak RS, Al-Hitmi MH, Islam KR, et al. Mortality Prediction Utilizing Blood Biomarkers to Predict the Severity of COVID-19 Using Machine Learning Technique. Diagnostics (Basel). 2021;11(9).
- Tiscia G, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, Colaizzo D, et al. The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting. Diagnostics (Basel). 2021;11(9).
- Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19–A systematic review. Life sciences. 2020;254:117788.
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-70.
- Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797-805.
- Stawinski PM, Dziadkowiec KN, Al-Abbasi B, Suarez L, Simms L, Dewaswala N, et al. Model of End-Stage Liver Disease (MELD) Score as a Predictor of In-Hospital Mortality in Patients with COVID-19: A Novel Approach to a Classic Scoring System. Cureus. 2021;13(5):e15179.
- Wernly B, Frutos-Vivar F, Peñuelas O, Raymondos K, Muriel A, Du B, et al. Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation. Eur J Intern Med. 2019;70:18-23.
- Bruno RR, Wernly B, Hornemann J, Flaatten H, FjØlner J, Artigas A, et al. Early evaluation of organ failure using MELD-XI in critically ill elderly COVID-19 patients. Clin Hemorheol Microcirc. 2021;79(1):109-20.